Safety of a 0.5mg Dose of hLF1-11 Given for 10 Consecutive Days to Autologous Haematopoietic Stem Cell Transplant Recipients.
Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 08 Jul 2015
At a glance
- Drugs Lactoferrin 1-11 (Primary)
- Indications Bacterial infections; Mycoses
- Focus Adverse reactions
- Sponsors AM-Pharma
- 12 Jan 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 14 Apr 2009 New source identified and integrated (Netherlands Trial Register NTR672).
- 16 Oct 2008 Planned end date changed from 1 Sep 2008 to 1 Jun 2009, as reported by ClinicalTrials.gov.